{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:42:24Z","timestamp":1790516544521,"version":"4.1.0"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2012,4,27]],"date-time":"2012-04-27T00:00:00Z","timestamp":1335484800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0033572","type":"journal-article","created":{"date-parts":[[2012,4,27]],"date-time":"2012-04-27T17:21:15Z","timestamp":1335547275000},"page":"e33572","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":151,"title":["Evaluation of SMN Protein, Transcript, and Copy Number in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study"],"prefix":"10.1371","volume":"7","author":[{"given":"Thomas O.","family":"Crawford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey V.","family":"Paushkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dione T.","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne J.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia L.","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Finkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J.","family":"Swoboda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Tiziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Lomastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca H.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia L.","family":"Trachtenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Plasterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Pilot Study of Biomarkers for Spinal Muscular Atrophy (BforSMA) Trial Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,4,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/338627","article-title":"Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy.","volume":"70","author":"M Feldkotter","year":"2002","journal-title":"Am J Hum Genet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00125817-200201000-00004","article-title":"Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2.","volume":"4","author":"MD Mailman","year":"2002","journal-title":"Genet Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/515465","article-title":"Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number.","volume":"60","author":"PE McAndrew","year":"1997","journal-title":"Am J Hum Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/hmg\/11.9.1017","article-title":"A novel association of the SMN protein with two major non-ribosomal nucleolar proteins and its implication in spinal muscular atrophy.","volume":"11","author":"S Lefebvre","year":"2002","journal-title":"Hum Mol Genet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/hmg\/9.5.675","article-title":"Characterization of the Schizosaccharomyces pombe orthologue of the human survival motor neuron (SMN) protein.","volume":"9","author":"N Owen","year":"2000","journal-title":"Hum Mol Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"23841","DOI":"10.1074\/jbc.M001441200","article-title":"The survival motor neuron protein of Schizosacharomyces pombe. Conservation of survival motor neuron interaction domains in divergent organisms.","volume":"275","author":"S Paushkin","year":"2000","journal-title":"J Biol Chem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1073\/pnas.94.18.9920","article-title":"Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos.","volume":"94","author":"B Schrank","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"45387","DOI":"10.1074\/jbc.M105059200","article-title":"Characterization of functional domains of the SMN protein in vivo.","volume":"276","author":"J Wang","year":"2001","journal-title":"J Biol Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.nurt.2008.08.007","article-title":"Spinal muscular atrophy.","volume":"5","author":"M Oskoui","year":"2008","journal-title":"Neurotherapeutics"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00439-006-0245-7","article-title":"Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts.","volume":"120","author":"VB Mattis","year":"2006","journal-title":"Hum Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5ra12","DOI":"10.1126\/scitranslmed.3000208","article-title":"Tetracyclines that promote SMN2 exon 7 splicing as therapeutics for spinal muscular atrophy.","volume":"1","author":"ML Hastings","year":"2009","journal-title":"Sci Transl Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","article-title":"Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy.","volume":"3","author":"MA Passini","year":"2011","journal-title":"Sci Transl Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI41615","article-title":"CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy.","volume":"120","author":"MA Passini","year":"2010","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN.","volume":"28","author":"KD Foust","year":"2010","journal-title":"Nat Biotechnol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"35ra42","DOI":"10.1126\/scitranslmed.3000830","article-title":"Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy.","volume":"2","author":"CF Valori","year":"2010","journal-title":"Sci Transl Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/hmg\/ddq514","article-title":"Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice.","volume":"20","author":"E Dominguez","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1212\/01.wnl.0000249142.82285.d6","article-title":"Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy.","volume":"68","author":"E Mercuri","year":"2007","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1212\/WNL.0b013e3182020332","article-title":"Randomized, double-blind, placebo-controlled trial of hydroxyurea in spinal muscular atrophy.","volume":"75","author":"TH Chen","year":"2010","journal-title":"Neurology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e12140","DOI":"10.1371\/journal.pone.0012140","article-title":"SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy.","volume":"5","author":"KJ Swoboda","year":"2010","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.nmd.2004.04.004","article-title":"Concerns about the design of clinical trials for spinal muscular atrophy.","volume":"14","author":"TO Crawford","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"ref21","first-page":"20103731","article-title":"Observational Study of Spinal Muscular Atrophy Type 2 and 3: Functional Outcomes Over 1 Year. Arch Neurol.","volume":"0","author":"P Kaufmann","year":"2011"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","article-title":"International SMA consortium meeting. (26\u201328 June 1992, Bonn, Germany).","volume":"2","author":"TL Munsat","year":"1992","journal-title":"Neuromuscul Disord"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1212\/01.wnl.0000201929.56928.13","article-title":"SMN mRNA and protein levels in peripheral blood: biomarkers for SMA clinical trials.","volume":"66","author":"CJ Sumner","year":"2006","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2377-6-6","article-title":"A novel cell immunoassay to measure survival of motor neurons protein in blood cells.","volume":"6","author":"SJ Kolb","year":"2006","journal-title":"BMC Neurol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/sj.ejhg.5201885","article-title":"A sensitive assay for measuring SMN mRNA levels in peripheral blood and in muscle samples of patients affected with spinal muscular atrophy.","volume":"15","author":"M Vezain","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/ejhg.2009.116","article-title":"SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR.","volume":"18","author":"FD Tiziano","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1212\/01.wnl.0000252934.70676.ab","article-title":"Preclinical validation of a multiplex real-time assay to quantify SMN mRNA in patients with SMA.","volume":"68","author":"LR Simard","year":"2007","journal-title":"Neurology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.nmd.2006.03.015","article-title":"A modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophy.","volume":"16","author":"KJ Krosschell","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/01.wnl.0000290830.40544.b9","article-title":"The changing natural history of spinal muscular atrophy type 1.","volume":"69","author":"M Oskoui","year":"2007","journal-title":"Neurology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10048-007-0093-1","article-title":"Robust quantification of the SMN gene copy number by real-time TaqMan PCR.","volume":"8","author":"I Gomez-Curet","year":"2007","journal-title":"Neurogenetics"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/sj.ejhg.5201288","article-title":"New insights on the evolution of the SMN1 and SMN2 region: simulation and meta-analysis for allele and haplotype frequency calculations.","volume":"12","author":"S Ogino","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/jmg.2009.066969","article-title":"Differences in SMN1 allele frequencies among ethnic groups within North America.","volume":"46","author":"BC Hendrickson","year":"2009","journal-title":"J Med Genet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1086\/513913","article-title":"When is a deletion not a deletion? When it is converted.","volume":"61","author":"AH Burghes","year":"1997","journal-title":"Am J Hum Genet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1086\/301608","article-title":"De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling.","volume":"61","author":"B Wirth","year":"1997","journal-title":"Am J Hum Genet"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1086\/302369","article-title":"Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling.","volume":"64","author":"B Wirth","year":"1999","journal-title":"Am J Hum Genet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajhg.2009.08.002","article-title":"A positive modifier of spinal muscular atrophy in the SMN2 gene.","volume":"85","author":"TW Prior","year":"2009","journal-title":"Am J Hum Genet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e3209","DOI":"10.1371\/journal.pone.0003209","article-title":"Modeling spinal muscular atrophy in Drosophila.","volume":"3","author":"HC Chang","year":"2008","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e1001172","DOI":"10.1371\/journal.pgen.1001172","article-title":"Conserved Genes Act as Modifiers of Invertebrate SMN Loss of Function Defects.","volume":"6","author":"M Dimitriadi","year":"2010","journal-title":"PLoS Genet"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1083\/jcb.201004016","article-title":"Modeling spinal muscular atrophy in Drosophila links Smn to FGF signaling.","volume":"192","author":"A Sen","year":"2011","journal-title":"J Cell Biol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.1155085","article-title":"Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy.","volume":"320","author":"GE Oprea","year":"2008","journal-title":"Science"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1261\/rna.1273209","article-title":"Differential 3&apos; splice site recognition of SMN1 and SMN2 transcripts by U2AF and U2 snRNP.","volume":"15","author":"M Martins de Araujo","year":"2009","journal-title":"Rna"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/MCB.00945-10","article-title":"TIA1 prevents skipping of a critical exon associated with spinal muscular atrophy.","volume":"31","author":"NN Singh","year":"2011","journal-title":"Mol Cell Biol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/emboj.2010.19","article-title":"The splicing regulator Sam68 binds to a novel exonic splicing silencer and functions in SMN2 alternative splicing in spinal muscular atrophy.","volume":"29","author":"S Pedrotti","year":"2010","journal-title":"Embo J"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","article-title":"Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice.","volume":"82","author":"Y Hua","year":"2008","journal-title":"Am J Hum Genet"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1128\/MCB.26.4.1333-1346.2006","article-title":"Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron.","volume":"26","author":"NK Singh","year":"2006","journal-title":"Mol Cell Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1261\/rna.7580704","article-title":"In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes.","volume":"10","author":"NN Singh","year":"2004","journal-title":"Rna"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/nar\/gkl1050","article-title":"Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes.","volume":"35","author":"NN Singh","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4161\/rna.6.3.8723","article-title":"A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy.","volume":"6","author":"NN Singh","year":"2009","journal-title":"RNA Biol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1128\/MCB.01332-08","article-title":"The RNA binding protein hnRNP Q modulates the utilization of exon 7 in the survival motor neuron 2 (SMN2) gene.","volume":"28","author":"HH Chen","year":"2008","journal-title":"Mol Cell Biol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ng1207","article-title":"A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy.","volume":"34","author":"T Kashima","year":"2003","journal-title":"Nat Genet"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1073\/pnas.0700343104","article-title":"An intronic element contributes to splicing repression in spinal muscular atrophy.","volume":"104","author":"T Kashima","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng854","article-title":"Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1.","volume":"30","author":"L Cartegni","year":"2002","journal-title":"Nat Genet"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1086\/498853","article-title":"Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2.","volume":"78","author":"L Cartegni","year":"2006","journal-title":"Am J Hum Genet"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e35462","DOI":"10.1371\/journal.pone.0035462","article-title":"Candidate Proteins, Metabolites and Transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study.","volume":"7","author":"RS Finkel","year":"2012","journal-title":"PLoS ONE"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0033572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T09:19:53Z","timestamp":1589015993000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0033572"}},"subtitle":[],"editor":[{"given":"Markus","family":"Schuelke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,27]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0033572","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,27]]}}}